Brandon Couillard analyst WELLS FARGO

Currently out of the existing stock ratings of Brandon Couillard, 56 are a HOLD (24.24%), 6 are a SELL (2.6%), 169 are a BUY (73.16%).

Brandon Couillard

Work Performance Price Targets & Ratings Chart

Analyst Brandon Couillard, currently employed at WELLS FARGO, carries an average stock price target met ratio of 68.06% that have a potential upside of 23.54% achieved within 383 days.

Brandon Couillard’s has documented 469 price targets and ratings displayed on 36 stocks. The coverage is on Healthcare, Basic Materials, Technology, Industrials, Energy sectors.

Most recent stock forecast was given on DHR, Danaher at 22-Jul-2026.

Wall Street Analyst Brandon Couillard

Analyst best performing recommendations are on CDNA (CAREDX).
The best stock recommendation documented was for EXAS (EXACT SCIENCES) at 10/31/2017. The price target of $60 was fulfilled within 7 days with a profit of $5.01 (9.11%) receiving and performance score of 13.02.

Average potential price target upside

A Agilent Technologies ALGN Align Technology AVTR Avantor BIO Bio-Rad Laboratories EXAS EXACT Sciences KEYS Keysight Technologies MYGN Myriad Genetics DHR Danaher WAT Waters BRKR Bruker CDXS Codexis OSUR OraSure Technologies RGEN Repligen ONVO Organovo Holdings SMFR Sema4 Holdings Corp OPK Opko Health TMO Thermo Fisher Scientific CYRX Cryoport SDC SmileDirectClub SLGC Somalogic MRVI Maravai Lifesciences Holdings  CDNA Caredx MTD Mettler-Toledo International PDCO Patterson Companies XRAY Dentsply Sirona GHDX Genomic Health LMNX Luminex QTNT Quotient Ltd MLAB Mesa Laboratories GH Guardant Health NTRA Natera TECH Bio-Techne Corp AA Alcoa Corp NAUT Nautilus Biotechnology RVTY Revvity SM SM Energy Co

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 09-Jul-2026

$135

$-3.57 (-2.58%)

$180

21 days ago
(09-Jul-2026)

8/10 (80%)

$1.41 (1.06%)

237

Buy Since 06-Apr-2026

$148

$9.43 (6.81%)

$140

24 days ago
(06-Jul-2026)

7/10 (70%)

$17.4 (13.32%)

27

Buy Since 26-Feb-2026

$150

$13.99 (10.29%)

$145

1 months 6 days ago
(24-Jun-2026)

16/22 (72.73%)

$18.37 (13.96%)

122

Buy Since 02-Jun-2026

$155

$18.99 (13.96%)

$145

1 months 28 days ago
(02-Jun-2026)

9/13 (69.23%)

$19.95 (14.77%)

164

Buy Since 24-May-2023

$155

$18.99 (13.96%)

$165

2 months 2 days ago
(28-May-2026)

15/20 (75%)

$19.62 (14.49%)

249

Show more analysts

Please expand the browser size to see the chart

Which stock is Brandon Couillard is most bullish on?

Potential upside of $48.04 has been obtained for RGEN (REPLIGEN)

Which stock is Brandon Couillard is most reserved on?

Potential downside of -$41.99 has been obtained for NTRA (NATERA)

What Year was the first public recommendation made by Brandon Couillard?

On 2007

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?